Literature DB >> 19885015

Heme oxygenase-1 induced by aprotinin inhibits vascular smooth muscle cell proliferation through cell cycle arrest in hypertensive rats.

Hyoung Chul Choi1, Kwang Youn Lee, Dong Hyup Lee, Young Jin Kang.   

Abstract

Spontaneous hypertensive rats (SHR) are an established model of genetic hypertension. Vascular smooth muscle cells (VSMC) from SHR proliferate faster than those of control rats (Wistar-Kyoto rats; WKY). We tested the hypothesis that induction of heme oxygenase (HO)-1 induced by aprotinin inhibits VSMC proliferation through cell cycle arrest in hypertensive rats. Aprotinin treatment inhibited VSMC proliferation in SHR more than in normotensive rats. These inhibitory effects were associated with cell cycle arrest in the G1 phase. Tin protoporphyrin IX (SnPPIX) reversed the anti-proliferative effect of aprotinin in VSMC from SHR. The level of cyclin D was higher in VSMC of SHR than those of WKY. Aprotinin treatment downregulated the cell cycle regulator, cyclin D, but upregulated the cyclin-dependent kinase inhibitor, p21, in VSMC of SHR. Aprotinin induced HO-1 in VSMC of SHR, but not in those of control rats. Furthermore, aprotinin-induced HO-1 inhibited VSMC proliferation of SHR. Consistently, VSMC proliferation in SHR was significantly inhibited by transfection with the HO-1 gene. These results indicate that induction of HO-1 by aprotinin inhibits VSMC proliferation through cell cycle arrest in hypertensive rats.

Entities:  

Keywords:  Aprotinin; Cell cycle arrest; Heme oxygenase-1; Hypertension; Proliferation

Year:  2009        PMID: 19885015      PMCID: PMC2766711          DOI: 10.4196/kjpp.2009.13.4.309

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  24 in total

1.  Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump.

Authors:  Rui Wang; Rany Shamloul; Xiaoxia Wang; Qinghe Meng; Lingyun Wu
Journal:  Hypertension       Date:  2006-08-28       Impact factor: 10.190

2.  The risk associated with aprotinin in cardiac surgery.

Authors:  Dennis T Mangano; Iulia C Tudor; Cynthia Dietzel
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

3.  Aprotinin Inhibits Vascular Smooth Muscle Cell Inflammation and Proliferation via Induction of HO-1.

Authors:  Dong Hyup Lee; Hyoung Chul Choi; Kwang Youn Lee; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

Review 4.  Braking the cycle.

Authors:  T Hunter
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

5.  Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21.

Authors:  Eun Mi Jeon; Hyoung Chul Choi; Kwang Youn Lee; Ki Churl Chang; Young Jin Kang
Journal:  Arch Pharm Res       Date:  2009-04-23       Impact factor: 4.946

6.  Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?

Authors:  Lars Englberger; Beat Kipfer; Pascal A Berdat; Urs E Nydegger; Thierry P Carrel
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

7.  Heme oxygenase inhibits human airway smooth muscle proliferation via a bilirubin-dependent modulation of ERK1/2 phosphorylation.

Authors:  Camille Taillé; Abdelhamid Almolki; Moussa Benhamed; Christine Zedda; Jérôme Mégret; Patrick Berger; Guy Lesèche; Elie Fadel; Tokio Yamaguchi; Roger Marthan; Michel Aubier; Jorge Boczkowski
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

8.  Selective regulation of blood pressure by heme oxygenase-1 in hypertension.

Authors:  Joseph Fomusi Ndisang; Weimin Zhao; Rui Wang
Journal:  Hypertension       Date:  2002-09       Impact factor: 10.190

9.  Aprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion.

Authors:  Matthew D McEvoy; Anna-Greta Taylor; Juozas A Zavadzkas; Ira M Mains; Rachael L Ford; Robert E Stroud; Laura B Jeffords; Christy U Beck; Scott T Reeves; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2008-08       Impact factor: 4.330

10.  Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats.

Authors:  Joseph Fomusi Ndisang; Lingyun Wu; Weimin Zhao; Rui Wang
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

View more
  7 in total

Review 1.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

2.  Cilostazol Inhibits Vascular Smooth Muscle Cell Proliferation and Reactive Oxygen Species Production through Activation of AMP-activated Protein Kinase Induced by Heme Oxygenase-1.

Authors:  Jung Eun Kim; Jin Young Sung; Chang-Hoon Woo; Young Jin Kang; Kwang Youn Lee; Hee Sun Kim; Woo Hyung Kwun; Hyoung Chul Choi
Journal:  Korean J Physiol Pharmacol       Date:  2011-08-31       Impact factor: 2.016

3.  Insulin Like Growth Factor Binding Protein-5 Regulates Excessive Vascular Smooth Muscle Cell Proliferation in Spontaneously Hypertensive Rats via ERK 1/2 Phosphorylation.

Authors:  Dong Hyup Lee; Jung Eun Kim; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2013-04-10       Impact factor: 2.016

4.  Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells.

Authors:  Ae-Rang Hwang; Jung-Hwa Han; Jae Hyang Lim; Young Jin Kang; Chang-Hoon Woo
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

5.  SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1.

Authors:  Margit Schwartz; Sabine Böckmann; Philipp Borchert; Burkhard Hinz
Journal:  Oncotarget       Date:  2018-05-01

6.  Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction.

Authors:  Tian-Meng Chen; Jian Li; Lin Liu; Li Fan; Xiao-Ying Li; Yu-Tang Wang; Nader G Abraham; Jian Cao
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

7.  Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMC.

Authors:  Yu Mi Ha; Ju-Ock Nam; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2015-10-16       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.